Accelerate Brain Cancer Cure Inc.

Fiscal year ending 2019. Filed on November 16, 2020.

1717 Rhode Island Avenue NW No 7
770
Washington, District of Columbia 20036

Accelerate Brain Cancer Cure Inc. (EIN: 52-2320756) has filed an IRS Form 990 from fiscal year 20162019. In its fiscal year 2019 IRS Form 990 filing, Accelerate Brain Cancer Cure Inc., a 501(c)(3) charitable organization, reported compensation for 2 out of 6 total employees. Among the employees shown here, the average compensation is $442,245. The highest compensated employee at Accelerate Brain Cancer Cure Inc. is Max Wallace with fiscal year 2019 compensation of $552,877.

Revenue, expenses, and employee compensation

Revenue

$1,166,711

Expenses

$3,986,099

Employee compensation

$1,152,879
Revenue, expenses, and employee compensation over time

Mission Statement

TO ACCELERATE PROGRESS IN WHAT HAS BEEN AN UNDERSERVED FIELD OF RESEARCH; THE ORGANIZATION AIMS TO RAISE AWARENESS ABOUT BRAIN CANCER AND HELP MOBILIZE CRITICAL SCIENTIFIC RESEARCH THROUGH RESEARCH GRANTS.

Revisions to this organization profile

November 16, 2020:
2019 Accelerate Brain Cancer Cure Inc. 990 filed
November 15, 2019:
2018 Accelerate Brain Cancer Cure Inc. 990 filed
November 8, 2018:
2017 Accelerate Brain Cancer Cure Inc. 990 filed

Get an email when new compensation information is released for Accelerate Brain Cancer Cure Inc.

Be the first to know when new IRS Form 990 data is published for this organization.

Related Jobs

Powered by Talroo